Open with CtrlK — press Esc to close
Mice engineered so that a piece of one blood vessel protein can no longer be cut away grew normal blood vessels but reacted far less to inflammation, researchers at Heidelberg University and the…
Researchers at Virginia Tech report that two meals matched to within 1.6% on calories, fat, carbohydrate, protein, fiber and salt still produced different responses in the body, depending on whether…
A review of 53 studies reports climate-linked harm to Indigenous children's health in the communities those studies covered, across five areas. It was published on Sept. 30, 2026, in the journal…
The Food and Drug Administration closed its outbreak investigation into recalled iceberg lettuce on Oct. 2 and reported that two of the samples it collected in Mexico tested positive for Cyclospora,…
The World Health Organization released new Global Health Estimates on Oct. 2, covering 2000 to 2023. WHO puts global life expectancy at 73.3 years at the end of that period, a tenth of a year below…
Bangladesh's health directorate and its national epidemiology institute have published the national tally for what they describe as the country's largest recorded measles outbreak. Nationwide…
The U.S. Food and Drug Administration approved the Autus Size-Adjustable Valve on October 1, 2026, a pulmonary heart valve for children with congenital pulmonary valve disease that is designed to be…
A UK-led group reported on October 1, 2026, that bat coronaviruses able to use the widest range of animal receptors all sit in the same branch of the family as SARS-CoV-2, and that those are also the…
Siyu Liu, Douglas R. Higgs and colleagues at the University of Oxford have found the DNA switches that keep an embryonic blood gene shut off after early pregnancy, and report that disabling two of…
Researchers at Memorial Sloan Kettering Cancer Center in New York tracked 9,419 meals eaten by 173 patients hospitalized for a blood stem cell transplant and report in Nature that sweets eaten while…
The biotechnology company uniQure reported four-year results on Sept. 29 for 12 patients given a high dose of its experimental gene therapy for Huntington's disease. On the study's pre-chosen main…
Adicet Bio says every patient in an early-stage trial of its experimental lupus treatment stopped taking immunosuppressant drugs after a single dose. The company published the trial's first full year…
Medical Disclaimer: This content is provided for general informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition, concern, symptom, or treatment decision.